iTonic Holdings Ltd（ITOC）股票分析

$1.645

-0.053 (-3.24%)收盤時

Loading chart…

最高: 1.720
開盤: 1.630
成交量加權均價: 1.67
成交量: 6.05K
市值: —
最低: 1.630
成交金額: 10.07K
企業價值/稅息折舊攤銷前利潤（TTM）: 0.00

iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.

www.ftzy.com.cn/ir

AI 分析 of iTonic Holdings Ltd (ITOC)

賣出

iTonic Holdings Ltd (ITOC) is not a good buy right now due to its extremely low RSI of 16.645, indicating it is oversold, and a staggering year-to-date change of -88.61%.

估值指標

iTonic Holdings Ltd（ITOC）目前預期本益比為 0.00，5 年平均預期本益比為。

預期本益比

5 年均值 P/E

目前P/E

0.00

預期 EV/EBITDA

5 年均值 EV/EBITDA

目前EV/EBITDA

0.00

預期股價營收比

5 年均值 P/S

目前P/S

0.00

事件時間軸

2026-10-02 (ET)

09:30:00

iTonic Shareholders Approve 16-for-1 Share Consolidation

2026-02-06 (ET)

06:10:00

iTonic Holdings Files $200M Mixed Securities Shelf

查看更多事件

資訊

查看更多資訊

ITOC 常見問題 —— 由 Alphio AI 解答

iTonic Holdings Ltd (ITOC) is not a good buy right now due to its extremely low RSI of 16.645, indicating it is oversold, and a staggering year-to-date change of -88.61%.